Identifying novel genetic alterations in pediatric acute lymphoblastic leukemia based on copy number analysis

2Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Copy number variations (CNVs) analysis may reveal molecular biomarkers and provide information on the pathogenesis of acute lymphoblastic leukemia (ALL). We investigated the gene copy number in childhood ALL by microarray and select three new recurrent CNVs to evaluate by real-time PCR assay: DMBT1, KIAA0125 and PRDM16 were selected due to high frequency of CNVs in ALL samples and based on their potential biological functions in carcinogenesis described in the literature. DBMT1 deletion was associated with patients with chromosomal translocations and is a potential tumor suppressor; KIAA0125 and PRDM16 may act as an oncogene despite having a paradoxical behavior in carcinogenesis. This study reinforces that microarrays/aCGH is it is a powerful tool for detection of genomic aberrations, which may be used in the risk stratification.

Cite

CITATION STYLE

APA

Batista-Gomes, J. A., Mello, F. A. R., De Oliveira, E. H. C., De Souza, M. P. C., Wanderley, A. V., Da Costa Pantoja, L., … Khayat, A. S. (2020). Identifying novel genetic alterations in pediatric acute lymphoblastic leukemia based on copy number analysis. Molecular Cytogenetics, 13(1). https://doi.org/10.1186/s13039-020-00491-5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free